324 related articles for article (PubMed ID: 24985034)
1. Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
D'Souza C; Henriques ST; Wang CK; Craik DJ
Eur J Med Chem; 2014 Dec; 88():10-8. PubMed ID: 24985034
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.
Cascales L; Henriques ST; Kerr MC; Huang YH; Sweet MJ; Daly NL; Craik DJ
J Biol Chem; 2011 Oct; 286(42):36932-43. PubMed ID: 21873420
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of the cyclotide MCoTI-II, a cyclic disulfide-rich peptide drug scaffold.
Wang CK; Stalmans S; De Spiegeleer B; Craik DJ
J Pept Sci; 2016 May; 22(5):305-10. PubMed ID: 26929247
[TBL] [Abstract][Full Text] [Related]
4. High-affinity cyclic peptide matriptase inhibitors.
Quimbar P; Malik U; Sommerhoff CP; Kaas Q; Chan LY; Huang YH; Grundhuber M; Dunse K; Craik DJ; Anderson MA; Daly NL
J Biol Chem; 2013 May; 288(19):13885-96. PubMed ID: 23548907
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characterization of chimeric cyclotides from the Möbius and trypsin inhibitor subfamilies.
Abdul Ghani H; Henriques ST; Huang YH; Swedberg JE; Schroeder CI; Craik DJ
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27487329
[TBL] [Abstract][Full Text] [Related]
6. The Prototypic Cyclotide Kalata B1 Has a Unique Mechanism of Entering Cells.
Henriques ST; Huang YH; Chaousis S; Sani MA; Poth AG; Separovic F; Craik DJ
Chem Biol; 2015 Aug; 22(8):1087-97. PubMed ID: 26278183
[TBL] [Abstract][Full Text] [Related]
7. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.
Chan LY; Gunasekera S; Henriques ST; Worth NF; Le SJ; Clark RJ; Campbell JH; Craik DJ; Daly NL
Blood; 2011 Dec; 118(25):6709-17. PubMed ID: 22039263
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of cyclic disulfide-rich peptides.
Akcan M; Craik DJ
Methods Mol Biol; 2013; 1047():89-101. PubMed ID: 23943480
[TBL] [Abstract][Full Text] [Related]
9. Fmoc-based synthesis of disulfide-rich cyclic peptides.
Cheneval O; Schroeder CI; Durek T; Walsh P; Huang YH; Liras S; Price DA; Craik DJ
J Org Chem; 2014 Jun; 79(12):5538-44. PubMed ID: 24918986
[TBL] [Abstract][Full Text] [Related]
10. Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.
Chan LY; Craik DJ; Daly NL
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26464514
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins.
Heitz A; Hernandez JF; Gagnon J; Hong TT; Pham TT; Nguyen TM; Le-Nguyen D; Chiche L
Biochemistry; 2001 Jul; 40(27):7973-83. PubMed ID: 11434766
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
13. Racemic and quasi-racemic X-ray structures of cyclic disulfide-rich peptide drug scaffolds.
Wang CK; King GJ; Northfield SE; Ojeda PG; Craik DJ
Angew Chem Int Ed Engl; 2014 Oct; 53(42):11236-41. PubMed ID: 25168664
[TBL] [Abstract][Full Text] [Related]
14. Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1.
Korsinczky ML; Clark RJ; Craik DJ
Biochemistry; 2005 Feb; 44(4):1145-53. PubMed ID: 15667208
[TBL] [Abstract][Full Text] [Related]
15. Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.
Chaudhuri D; Aboye T; Camarero JA
Biochem J; 2019 Jan; 476(1):67-83. PubMed ID: 30635453
[TBL] [Abstract][Full Text] [Related]
16. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure.
Hernandez JF; Gagnon J; Chiche L; Nguyen TM; Andrieu JP; Heitz A; Trinh Hong T; Pham TT; Le Nguyen D
Biochemistry; 2000 May; 39(19):5722-30. PubMed ID: 10801322
[TBL] [Abstract][Full Text] [Related]
17. Using the MCoTI-II Cyclotide Scaffold To Design a Stable Cyclic Peptide Antagonist of SET, a Protein Overexpressed in Human Cancer.
D'Souza C; Henriques ST; Wang CK; Cheneval O; Chan LY; Bokil NJ; Sweet MJ; Craik DJ
Biochemistry; 2016 Jan; 55(2):396-405. PubMed ID: 26685975
[TBL] [Abstract][Full Text] [Related]
18. Knots in rings. The circular knotted protein Momordica cochinchinensis trypsin inhibitor-II folds via a stable two-disulfide intermediate.
Cemazar M; Daly NL; Häggblad S; Lo KP; Yulyaningsih E; Craik DJ
J Biol Chem; 2006 Mar; 281(12):8224-32. PubMed ID: 16547012
[TBL] [Abstract][Full Text] [Related]
19. Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs.
Colgrave ML; Korsinczky MJ; Clark RJ; Foley F; Craik DJ
Biopolymers; 2010; 94(5):665-72. PubMed ID: 20564016
[TBL] [Abstract][Full Text] [Related]
20. Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals.
Boy RG; Mier W; Nothelfer EM; Altmann A; Eisenhut M; Kolmar H; Tomaszowski M; Krämer S; Haberkorn U
Mol Imaging Biol; 2010 Aug; 12(4):377-85. PubMed ID: 19937135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
